D-0415-2018 Class II Terminated
FDA drug recall D-0415-2018 was initiated by Hetero Labs Limited Unit V on Dec 22, 2017 and is designated Class II. Reason for recall: Temperature Abuse: Complaints of tablets being wet and stuck together with tablet coating peeled and disintegrated as a result of prolonged exposure to high temp during distribution. The recall status is terminated (terminated Feb 5, 2020). Affected quantity: 8,436 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 21, 2018
- Initiation Date
- Dec 22, 2017
- Termination Date
- Feb 5, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,436 bottles
Product description
Famciclovir Tablets, 500 mg, 30-count bottles, Rx Only, Manufactured For: Camber Pharmaceuticals. Inc. Piscataway, NJ 08854 By: HETERO, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar-509 301, India. NDC 31722-708-30
Reason for recall
Temperature Abuse: Complaints of tablets being wet and stuck together with tablet coating peeled and disintegrated as a result of prolonged exposure to high temp during distribution.
Distribution pattern
Nationwide in the USA.
Code information
Lot # FMC17039, Exp 07/2019.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0415-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026